Immunodeficiency 46 (IMD46) Cell Models for Research

Immunodeficiency 46 (IMD46) is a rare primary immunodeficiency disorder caused by mutations in the ZNF341 gene. The exact prevalence is unknown, but it is estimated to affect less than 1 in 1,000,000 individuals worldwide. The condition is inherited in an autosomal recessive manner. Clinically, IMD46 presents with recurrent infections, particularly sinopulmonary infections, and is associated with hyper-IgE syndrome-like features, including elevated serum IgE levels, eczema, and susceptibility to fungal and bacterial infections. Without proper management, patients may experience severe complications, including chronic lung disease and invasive infections. Early diagnosis and treatment with immunoglobulin replacement and prophylactic antibiotics improve outcomes. The disease is recognized by the World Health Organization (WHO) and classified under primary immunodeficiencies. Research on IMD46 is crucial for understanding the molecular mechanisms of immune regulation and for developing targeted therapies.

IMD46 serves as an excellent model for studying the role of ZNF341 in immune cell function and gene regulation. ZNF341 is a transcription factor that regulates the expression of STAT3, a key player in cytokine signaling and immune responses. Mutations in ZNF341 lead to defective STAT3 expression, resulting in impaired Th17 cell differentiation and altered immune responses. This disease provides a unique opportunity to investigate the molecular pathways underlying primary immunodeficiencies and to explore potential therapeutic targets. Public datasets, such as those from the NCBI Gene and ClinVar, provide valuable information on ZNF341 mutations and their clinical significance. Open questions include the precise downstream targets of ZNF341 and the mechanisms by which specific mutations affect protein function. Gene-edited cell models, such as ZNF341 knockout cell lines, are essential tools for functional studies and drug discovery.

Although IMD46 is not a cancer, the molecular pathways involved are relevant to immune regulation and may have implications for cancer susceptibility. The primary pathway affected is the JAK-STAT signaling pathway, which is critical for cytokine-mediated immune responses. The steps are as follows:

1. Cytokine binding to its receptor activates JAK kinases.

2. JAKs phosphorylate STAT3, leading to its dimerization and nuclear translocation.

3. In the nucleus, STAT3 regulates the transcription of target genes involved in cell proliferation, differentiation, and immune function.

In IMD46, ZNF341 mutations lead to reduced ZNF341 protein levels, which in turn decreases STAT3 expression. This results in impaired STAT3 signaling and downstream effects on Th17 cell differentiation and antimicrobial peptide production. Additionally, ZNF341 may have other targets beyond STAT3, contributing to the complex phenotype.

The primary genetic alterations in IMD46 are mutations in the ZNF341 gene. According to ClinVar and COSMIC, the most common mutation types include missense, nonsense, and frameshift mutations that lead to loss of function. The table below summarizes the genetic alterations observed in IMD46:

These mutations are inherited in an autosomal recessive manner, meaning that affected individuals carry two mutated alleles. The functional effect is a loss of ZNF341 function, leading to decreased STAT3 expression and impaired immune responses.

The deregulated signaling networks in IMD46 primarily involve the JAK-STAT pathway, but also affect other interconnected networks. Key nodes include:

• • ZNF341: Transcription factor that regulates STAT3 expression.
• • STAT3: Critical mediator of cytokine signaling, particularly IL-6 and IL-23.
• • Th17 cells: CD4+ T cells that produce IL-17, important for mucosal immunity.
• • Antimicrobial peptides: Defensins and cathelicidins, which are regulated by STAT3 and are crucial for epithelial defense.

Additionally, ZNF341 may interact with other transcription factors and co-regulators, influencing broader gene expression programs. The PI3K/AKT and MAPK pathways may also be indirectly affected due to altered cytokine signaling. Understanding these networks is essential for identifying potential therapeutic targets.

Several cell lines are commonly used to study IMD46 and ZNF341 function. The table below lists some relevant cell lines and their characteristics:

Organoids, particularly intestinal and lung organoids, are also valuable for studying epithelial immune responses. They can be derived from patient samples or genetically engineered to carry ZNF341 mutations, providing a more physiologically relevant model.

Animal models are crucial for studying IMD46 in vivo. The following models are commonly used:

• • ZNF341 knockout mice: These mice exhibit immune defects similar to human IMD46, including reduced STAT3 expression and impaired Th17 responses.
• • Patient-derived xenograft (PDX) models: Although not applicable for immunodeficiency, PDX models can be used for studying related cancers if they arise.
• • Genetically engineered mouse models (GEMM): Mice with specific ZNF341 mutations can be generated to study genotype-phenotype correlations.
• • Induced models: Conditional knockout mice using Cre-lox systems allow tissue-specific deletion of ZNF341.

These models are essential for understanding the systemic effects of ZNF341 deficiency and for testing therapeutic interventions.

Gene-edited cell models are powerful tools for studying IMD46. CRISPR-Cas9 technology enables the generation of isogenic cell lines with specific ZNF341 mutations, providing a controlled system to investigate the functional consequences of these mutations. For example:

• • ZNF341 knockout cell lines: These cells have complete loss of ZNF341 function, mimicking the null mutations seen in IMD46. They are useful for studying the downstream effects on STAT3 expression and immune signaling.
• • ZNF341 point-mutation knock-in cell lines: These cells carry specific missense mutations identified in patients, allowing for the study of hypomorphic alleles and their impact on protein function.

These gene-edited models are commercially available from various sources and are sequence-verified to ensure accuracy. They accelerate research by providing reproducible and genetically defined systems for drug screening, functional genomics, and target validation.

Gene-edited cell lines are invaluable for functional genomics studies. By knocking out ZNF341, researchers can identify genes and pathways that are dependent on ZNF341 function. For example, transcriptomic analysis of ZNF341 knockout cells can reveal differentially expressed genes involved in immune responses. Additionally, CRISPR screens using ZNF341 knockout cells can identify synthetic lethal partners or suppressors of the phenotype. These studies help elucidate the molecular mechanisms underlying IMD46 and may uncover novel therapeutic targets.

Isogenic cell line pairs, differing only in the ZNF341 mutation, are ideal for drug screening. They allow researchers to identify compounds that selectively affect ZNF341-deficient cells, potentially leading to targeted therapies. For example, a screen could identify drugs that restore STAT3 expression or compensate for its loss. Additionally, these models can be used to study drug resistance mechanisms, as ZNF341 deficiency may alter cellular responses to certain agents. This is particularly relevant for immunomodulatory drugs used in the treatment of primary immunodeficiencies.

CRISPR-based synthetic lethality screens using ZNF341 knockout cells can identify genes whose loss is lethal only in the context of ZNF341 deficiency. These genes could serve as biomarkers for disease severity or as potential drug targets. For example, if a specific kinase is essential for the survival of ZNF341-deficient cells, inhibitors of that kinase could be developed as targeted therapies. Additionally, gene expression profiling of ZNF341 knockout cells can identify secreted proteins that could serve as diagnostic biomarkers for IMD46.

The following public databases provide valuable data for IMD46 research: